Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by chronic inflammation. Lupus nephritis is a severe manifestation of SLE affecting about 50% of SLE patients with high morbidity and mortality. Adiponectin has anti-inflammatory properties. Adiponectin could be a factor linking inflammation in SLE and lupus nephritis (LN). Aim of the Work: To assess the level of serum & urinary adiponectin in SLE patients and to detect any relation between serum & urinary adiponectin levels and SLE activity and lupus nephritis. Subjects and Methods: This study included 30 female SLE patients and 15 female age matched healthy controls. SLE patients were subjected to full history taking, clinical examination and laboratory investigations of SLE & LN. Disease activity and renal involvement were assessed using SLE Disease Activity Index (SLEDAI) and Renal SLEDAI respectively. Patients were divided into active versus inactive and LN versus non-LN. Renal biopsies were taken from LN subgroup. Serum & urinary levels of adiponectin were measured using enzyme-linked immunosorbent assay (ELISA) in all subjects. Results: Significantly higher serum & urinary adiponectin level was found in SLE patients when compared with controls.
INTRODUCTION
Systemic lupus erythematosus (SLE) is chronic autoimmune, multisystemic, relapsing, and remitting disease that is characterized by the production of autoantibodies directed against several antigens in multiple organs including joints, skin, serous membranes, kidneys, blood, central nervous system (CNS) and others organs 1, 2 . Renal involvement is very common in SLE affecting 50% adult subjects suffering from SLE 3 . Lupus nephritis (LN) is a severe manifestation of SLE, caused in most cases by the glomerular deposition of anti-dsDNA antibodies that locally activate complement, and elicit a strong inflammatory response 4 . LN may be presented by a Correspondence to Tamer A. Elbedewy, Department of Internal Medicine, Tanta University; Egypt. e-mail: tamerelbedewy2006@yahoo.com wide range of abnormalities ranging from asymptomatic proteinuria or microscopic hematuria with normal renal function, to severe nephrotic syndrome or renal failure 5 . Kidney biopsy may help to confirm the diagnosis, as well as providing useful view for the prognosis and decisions regarding therapy 6 . American College of Rheumatology (ACR) guidelines suggest that a kidney biopsy be performed when there are persistent abnormalities in the urinary sediment or increased serum creatinine 7 . Adiponectin, is adipocytokine 244-amino acid (30-kDa) protein secreted predominantly by white adipose tissue closely linked to components of the metabolic syndrome and is structurally similar to complement component C1q 8 . Adiponectin present in many forms, the monomeric form of adiponectin seems to occur only in the adipocyte, whereas oligomeric complexes circulate in plasma as low molecular weight trimers (LMW), middle molecular weight hexamers (MMW), and high molecular weight Original Article multimers (HMW) 9 . The adiponectin gene is located on chromosome 3q27, a region associated with susceptibility for developing metabolic syndrome and type 2 diabetes. Polymorphisms of the adiponectin gene may be associated with alterations of adiponectin function and important clinical conditions 10 . Adiponectin has anti-inflammatory and antiatherosclerotic properties on endothelial cells by decreasing vascular inflammation, foam cell formation, and cell adhesion, which all are involved in the initiation and progression of vascular lesions 8 . Adiponectin inhibits tumour necrosis factor alpha (TNF-α) and interlukin-6 (IL-6) production, also both TNF-α and IL-6 suppress adiponectin production, which suggests the existence of a negative feedback between adiponectin and pro-inflammatory cytokines 11 . Adiponectin had a role in acute kidney injury in experimental animals (12) . A small number of studies had examined adiponectin in patients with kidney disease & showed patients with end-stage kidney disease had elevated circulating levels of adiponectin (13) . Plasma adiponectin was found to be markedly elevated in patients with nephrotic syndrome, and this was independent of glomerular filtration rate 14 . Finally, increased serum adiponectin levels predict the progression from macroalbuminuria to end stage renal disease in type 1 diabetic patients 15 . The aim of this study was to assess the level of serum & urinary adiponectin in SLE patients and to detect any relation between serum & urinary adiponectin levels and SLE activity and lupus nephritis.
SUBJECTS AND METHODS

Subjects
The present study was carried out on 30 female patients with SLE fulfilling at least 4 criteria of the 11 the updated (ACR) criteria 16 , they were selected from the internal medicine department in and out-patient in Tanta University Hospitals. 15 female age matched healthy subjects were also included in the study as control group. Consent was obtained from all subjects after full explanation of benefits and risks of the study.
Exclusion criteria
Patients with diabetes mellitus, high blood pressure (≥ 180/110), dyslipidemia, obesity (BMI ≥ 30), metabolic syndrome, heart failure, malignancies, overlap syndrome (coexistence of lupus with other connective tissue diseases), pregnancy, renal disease from any cause else, liver disease, documented infection within the last 2 weeks or patients on hemodialysis were excluded. 
Methods
Statistics
Statistical presentation and analysis of the present study was conducted, as continuous data were expressed as mean ± standard deviation. Comparison of continuous data between two groups was made by using unpaired t for parametric data and MannWhitney tests for nonparametric data. Spearman & Pearson tests for correlations between different parameter (nonparametric & parametric respectively) were used. ROC curve were used for estimation of sensitivity, specificity, cut off level, positive predictive value and negative predictive value. Probability (P) values of less than 0.05 were considered statistical significant, if less than 0.01 were considered statistical highly significant & if more than 0.05 were considered statistical not significant. Analyses were performed using SPSS program, version 19 (SPSS Inc., Chicago, IL, USA).
RESULTS
This study included 30 female patients with SLE; their ages ranged from 15 to 32 years (mean 21.84±4.909), 19 active SLE patients (63.33%) with their SLEDAI ≥ 8 while the other 11 patients (36.67%) were inactive (SLEDAI < 8) and 15 patients (50%) had lupus nephritis (renal SLEDAI score ≥ 8) while 15 patients (50%) had no lupus nephritis (renal SLEDAI score < 8).
Renal biopsy revealed 8 patients had inflammatory LN classes (III & IV) and 7 patients had non-inflammatory LN classes (I & II)
. The other laboratory data of the patients were shown in (Table 2) .
This study also included 15 healthy female; their ages ranged from 17 to 32 years (mean 23.4±4.421).
Comparison between SLE patients & the control subjects were shown in (Table 3) .
Our results showed higher serum adiponectin level was found in SLE patients (mean 16.98±5.356 µg/ml) when compared with controls (mean 7.92±1.629 µ g/ml) with statistically highly significant difference (P<0.0001). Also higher urinary adiponectin level was found in SLE patients (mean 7.95±3.938 µg/g creatinine) when compared with controls (mean 2.73±0.3911 µg/g creatinine) with statistically highly significant difference (P <0.0001) ( Table 3) .
In the present study, Higher serum adiponectin level was found among SLE patients with LN (mean 19.997±5.999 µg/ml) when compared with SLE patients without LN (mean 13.97±1.995 µg/ml) with statistically significant difference (P=0.0235) ( Figure  1) . Higher urinary adiponectin level was found among SLE patients with LN (mean 10.94±3.4 µg/g creatinine) when compared with SLE patients without LN (mean 4.97±1.204 µg/g creatinine) with statistically highly significant difference (P<0.0001) (Figure 1 ). Other demographic and laboratory parameters comparing between SLE patients with LN & SLE patients without LN were shown in (Table 4) .
Our results showed higher serum adiponectin level was found among active SLE patients (mean 19.09±5.6 µg/ml) when compared with inactive patients (mean 13.34±1.935 µg/ml) with statistically highly significant difference (P = 0.0004) (Figure 1 ). Also higher urinary adiponectin level was found among active SLE patients (mean 9.50±4.146 µg/g creatinine) when compared with inactive patients (mean 5.28±1.271 µg/g creatinine) with statistically highly significant difference (P=0.0004) (Figure 1 ). Other demographic and laboratory parameters comparison between active & inactive SLE patients were shown in (Table 4) .
In the present study, Higher serum adiponectin level was found among inflammatory LN class (III & IV) patients (mean 23.73±4.821 µg/ml) when compared with non-inflammatory LN class (I & II) (mean 15.73±4.130 µg/ml) with statistically highly significant difference (P=0.0059). Higher urinary adiponectin level was found among inflammatory LN class (III & IV) patients (mean 13.67±1.796 µg/ml) when compared with non-inflammatory LN class (I & II) (mean 7.82±1.398 µg/ml) with statistically highly significant difference (P<0.0001) ( Table 5) .
In our SLE patients, Serum adiponectin had a significant positive correlation with SLEDAI (r=0.7282, P<0.0001) (Figure 2 ), renal SLEDAI (r=0.5176, P=0.0034) (Figure 3 ), ESR 1 st hour (r=0.6889, P<0.0001), proteinuria (r=0.4535, P=0.0118), anti-ds (DNA) titre (r=0.6435, P<0.0001) and LN class (r=0.5480, P=0.0344), while inverse correlation with C3 titre (r= -0.6343, P=0.0002) and C4 titre (r=-0.7414, P=0.0004) were recorded. Also serum adiponectin had a significant positive correlation with urinary adiponectin in SLE patients (r=0.4185, P=0.0214). On the other hand non-significant correlations between serum adiponectin and other demographic and laboratory parameters were recorded (Table 6 ). Also in our SLE patients, urinary adiponectin had a highly significant positive correlation with SLEDAI (r=0.5940, P=0.0005) (Figure 2 ), renal SLEDAI (r=0.8331, P<0.0001) (Figure 3) , ESR 1 st hour (r=0.5915, P=0.0006), proteinuria (r=0.7163, P<0.0001), anti-ds (DNA) titre (r=0.4581, P=0019) and LN class (r=0.7749, P=0.0007), while inverse correlation with creatinine clearance (r=-0.5122, P=0.0038), C3 titre (r=-0.7180, P<0.0001) and C4 titre (r=-0.6891, P<0.0001) were recorded. On the other hand non-significant correlations between urinary adiponectin and other demographic and laboratory parameters were recorded (Table 6 ).
ROC curve showed that the sensitivity and specificity of serum adiponectin for SLE activity at cut off level of 11.97 µg/ml was 100% & 36.36% respectively. The positive predictive value was 73.08% and the negative predictive value was 100%. The sensitivity and specificity of serum adiponectin for lupus nephritis at cut off level of 11.97 µg/ml was 100% & 26.67% respectively. The positive predictive value was 57.69% and the negative predictive value was 100% (Table 7) .
Also, ROC curve showed that the sensitivity and specificity of urinary adiponectin for SLE activity at cut off level of 7.145 µg/g creatinine was 73.68% & 90.91% respectively. The positive predictive value was 93.33% and the negative predictive value was 66.67%. The sensitivity and specificity of urinary adiponectin for lupus nephritis at cut off level of 7.145 µg/g creatinine was 93.33% for the both. The positive & negative predictive value was 93.33% for the both (Table 7) .
ROC curve showed that in patients with SLE, the sensitivity and specificity of anti-ds (DNA) for SLE activity at cut off level of 44.5 IU/ml was 100% & 72.73% respectively. The positive predictive value was 86.36% and the negative predictive value was 100%. The sensitivity and specificity of anti-ds (DNA) for lupus nephritis at cut off level of 44.5 IU/ml was 100% & 55.33% respectively. The positive predictive value was 68.18% and the negative predictive value was 100% (Table 7) . 
DISCUSSION
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by chronic inflammation and the production of autoantibodies directed against numerous antigens. SLE targets multiple organ systems including joints, skin, kidneys, CNS and others organs 1, 2 . Renal involvement is common in SLE affecting 50% adult subjects suffering from SLE 3 . Adiponectin is adipocytokine has anti-inflammatory properties 8 . However, its role in SLE & lupus nephritis remains to be clarified, so the aim of this study to assess the level of serum & urinary adiponectin in SLE patients and to detect any relation between serum & urinary adiponectin levels and SLE activity & lupus nephritis.
In this study, a statistically significant higher serum adiponectin level was found in SLE patients when compared with controls. This is in agreement with Sada et 26 found that serum HMW-adiponectin levels were lower in the patients than in the controls at baseline.
Our study showed significantly higher urinary adiponectin level in SLE patients when compared to controls and significantly higher urinary adiponectin level among SLE patients with LN when compared to patients without LN, this is concided with Rovin et al. study in 2005 27 , who stated that urine adiponectin levels increased significantly with renal flare, but not non renal SLE flare.
In our study, there was significantly higher serum adiponectin level among SLE patients with LN compared to SLE patients without LN, this is in agreement with Rovin et al. study in 2005 27 , who demonstrated that plasma adiponectin levels are increased in patients with renal SLE compared to healthy controls and patients with non renal SLE.
Our result showed higher serum & urinary adiponectin level among inflammatory LN class (III & IV) patients when compared with non-inflammatory LN class (I & II) with statistically highly significant difference. Also Rovin et al. study in 2005 27 demonstrated that, at renal flare the mean plasma adiponectin level in the inflammatory group (class III, IV) was significantly higher than the mean level in the non inflammatory group (class Ι, Π &V).
In the present study, there was significantly higher serum adiponectin level among active SLE patients compared to inactive patients. Also there was significantly higher urinary adiponectin level among active SLE patients compared to inactive SLE patients In our SLE patients, serum adiponectin had a highly significant positive correlation with SLEDAI, renal SLEDAI, ESR, proteinuria, anti-ds DNA and LN class while inverse correlation with C3, and C4 were recorded. Zoccali 22 stated that ESR and adiponectin were found to be markedly negatively correlated, but no correlation with CRP. However, in our study we did not find a statistical correlation between adiponectin and BMI due to our patients were selected in normal range of BMI.
Our results demonstrated that, urinary adiponectin had a highly significant positive correlation with SLEDAI, renal SLEDAI, ESR, proteinuria, anti-ds DNA and LN class while inverse correlation with creatinine clearance, C3 titre and C4 titre was recorded. Rovin et al. study in 2005 27 stated that, at renal flare, a significant positive correlation between urine adiponectin and urine protein, serum creatinine.
In the present study, serum adiponectin had a significant positive correlation with urinary adiponectin in SLE patients, this is in agreement with Rovin et al. study in 2005 27 , who stated that significant correlations between urine and plasma adiponectin. Some reports surprisingly suggest proinflammatory action of adiponectin 29, 30 . It has been evidenced that the serum concentration of adiponectin is elevated in patients with chronic/autoimmune inflammatory conditions 11 . Although elevated adiponectin levels could be explained by a compensatory response against inflammation, some researchers find this explanation unconvincing and point to the role of adiponectin in NFκB activation 29, 30 . This bidirectional, anti-and pro-inflammatory effects of adiponectin may in part result from the changes in the relative proportion of its various isoforms. LMW adiponectin has been shown to block endotoxininduced secretion of IL-6 and to induce IL-10 production (anti-inflammatory effects), while MMW and HMW adiponectin has been found to stimulate monocyte chemoattractant protein-1(MCP-1) and IL-8 synthesis higher amounts of this isoform may result in pro-inflammatory properties of adiponectin 31 . These findings imply that measurement of adiponectin multimers may adds significant value in assessing role of the adiponectin compared to total adiponectin alone. Certainly, it cannot be excluded that adiponectin production and secretion is regulated in a disease-dependent manner and that adiponectin action depends on a type of inflammatory disorder a patient suffers from.
Conclusion
Serum & urinary adiponectin levels are elevated in SLE patients and strongly associated with lupus activity & LN. Serum adiponectin can't be used as diagnostic test for SLE activity due to very low specificity (36.36%). Urinary adiponectin can be used as diagnostic test for LN with high sensitivity (93.33%) & high specificity (93.33%) and better than anti ds (DNA), but serum adiponectin can't be used as diagnostic test for LN due to very low specificity (26.67%). Serum & urinary adiponectin may consider promising biomarkers for prediction of SLE activity & renal involvement especially urinary adiponectin in lupus nephritis. Further study for measurement of adiponectin multimers in SLE & LN is recommended.
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